(0)

Nihonbashi Life Science HUB

2024年1月15日 (月) 午前 10:00 - 2024年1月16日 (火) 午後 6:00

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

8th DIA Cell and Gene Therapy Products Symposium in Japan

概要

8th DIA Cell and Gene Therapy Products Symposium in Japan

 “Development of Cell and Gene Therapy Products in the New Growth Phase”

 

Click Here to View the Japanese Program

 

Click Here to View the English Program

 

参加対象

  •  Individuals involved in the development of regenerative medical products in pharmaceutical or medical device companies and related industries.
  • Individuals involved in the development of regenera - tive medical products in venture companies or academic institutions.
  • Individuals involved in regulatory submissions work for regenerative medical products.

プログラム委員会

  • Kiyoshi Okada, MD, PhD
    Kiyoshi Okada, MD, PhD Vice Director, Medical Ctr for Translational Research,Dept of Medical Innovation
    Osaka University Hospital, Japan
  • Hiromi Okabe, PhD
    Hiromi Okabe, PhD Immunology, Regulatory Affairs Japan,Global Drug Development Division
    Novartis Pharma K.K, Japan
  • Yasuko Terao, PhD
    Yasuko Terao, PhD Head, External Scientific Engagement, R&D Japan Region,
    Takeda Pharmaceutical Co., Ltd., Japan
  • Teruyo Arato, PhD
    Teruyo Arato, PhD Professor, Clinical Research and Medical Innovation Center
    Hokkaido University Hospital, Japan
  • Satoru Hayata, MS
    Satoru Hayata, MS
    Sobi Japan, Japan
  • Ryutaro Hirasawa
    Ryutaro Hirasawa CMC Regulatory Affairs, Associate Director
    Daiichi Sankyo Co., Ltd., Japan
  • Akiko Ikeda, RPh
    Akiko Ikeda, RPh
    KalVista Pharmaceuticals Japan K.K., Japan
  • Ikuo Kawauchi
    Ikuo Kawauchi Senior Expert,International Standards Promotion Office,Intellectual Property Div
    FUJIFILM Holdings Corporation, Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。